An AllTrials project

NCT03431090: An ongoing trial by Nationwide Children's Hospital

This trial is ongoing. It must report results 9 months from now.

Full data

Full entry on ClinicalTrials.gov NCT03431090
Title HAPLEUK17, Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date March 2, 2018
Completion date Dec. 31, 2024
Required reporting date Dec. 31, 2025, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov March 28, 2025
Days late None